NHAS
ALGS icon

Novo Holdings A/S’s Aligos Therapeutics ALGS Stock Holding History

Novo Holdings A/S’s Portfolio ALGS Stock Details ALGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-78,000
Closed -$2.15M – 49
2022
Q3 		$2.15M Hold
78,000
– – 0.1% 51
2022
Q2 		$2.36M Hold
78,000
– – 0.12% 53
2022
Q1 		$4.19M Sell
78,000
-26,583
-25% -$2.13M 0.22% 46
2021
Q4 		$31M Hold
104,583
– – 1.47% 13
2021
Q3 		$40.6M Hold
104,583
– – 2.1% 12
2021
Q2 		$53.3M Hold
104,583
– – 2.36% 11
2021
Q1 		$59.5M Hold
104,583
– – 2.46% 13
2020
Q4 		$72.3M Buy
+104,583
New +$50.9M 3.1% 12

Other funds holding ALGS

EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return